Home › NDC Lookup › RxCUI directory › RxCUI 995232

Hydroxyzine pamoate 100 MG Oral Capsule — RxCUI 995232

RxNorm drug concept · Semantic clinical drug
RxCUI 995232 Semantic clinical drug · SCD ● Current RxNorm concept 8 FDA products 21 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI995232
Official nameHydroxyzine pamoate 100 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ashydroxyzine hydrochloride 100 MG (hydroxyzine pamoate 170.4 MG) Oral Capsule
FDA products mapped8
Package NDCs mapped21
Reported Medicaid activity (SDUD)127,756 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Hydroxyzine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Hydroxyzine is most often used to relieve anxiety and tension, or to control itching from allergic conditions like hives or eczema. It's also used as a calming medication before su...
  • Drowsiness is the most common side effect — it's actually how the medication works, so some sleepiness is expected, especially when you first start. For most people it gets better...
  • This is really important to go over with your pharmacist or doctor, because hydroxyzine interacts with a number of common drugs. Combining it with alcohol, opioid pain medicines, s...
  • Can I take hydroxyzine with my other medications?
📖 Read our full Hydroxyzine guide →

🕸️ Concept Web — How Hydroxyzine pamoate 100 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Hydroxyzine pamoate 100 MG Oral Capsule RxCUI 995232

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Hydroxyzine 5553
    • Hydroxyzine pamoate 203182
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Hydroxyzine Oral Capsule 370662
    • Hydroxyzine pamoate Oral Capsule 2649167
    • Hydroxyzine Oral Product 1164646
    • Hydroxyzine Pill 1164647
    • Hydroxyzine pamoate Oral Product 2660542
    • Hydroxyzine pamoate Pill 2659655
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Hydroxyzine pamoate 100 MG 1484094

Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Hydroxyzine pamoate 100 MG SCDC · 1484094
  • Hydroxyzine Oral Capsule SCDF · 370662
  • Hydroxyzine pamoate Oral Capsule SCDFP · 2649167
  • Hydroxyzine Oral Product SCDG · 1164646
  • Hydroxyzine Pill SCDG · 1164647
  • Hydroxyzine pamoate Oral Product SCDGP · 2660542
  • Hydroxyzine pamoate Pill SCDGP · 2659655

📦 FDA Products & Package NDCs

8 products · 21 package NDCs
21 package NDCs map to RxCUI 995232 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00555-0302-02 100 CAPSULE in 1 BOTTLE (0555-0302-02) Hydroxyzine Pamoate Teva Pharmaceuticals USA, Inc. 1984-07-01
00555-0302-04 500 CAPSULE in 1 BOTTLE (0555-0302-04) Hydroxyzine Pamoate Teva Pharmaceuticals USA, Inc. 1984-07-01
00555-0323-02 100 CAPSULE in 1 BOTTLE (0555-0323-02) Hydroxyzine Pamoate Teva Pharmaceuticals USA, Inc. 1984-07-01
00555-0323-04 500 CAPSULE in 1 BOTTLE (0555-0323-04) Hydroxyzine Pamoate Teva Pharmaceuticals USA, Inc. 1984-07-01
00555-0324-02 100 CAPSULE in 1 BOTTLE (0555-0324-02) Hydroxyzine Pamoate Teva Pharmaceuticals USA, Inc. 1984-07-01
63629-9244-01 30 CAPSULE in 1 BOTTLE (63629-9244-1) Hydroxyzine Pamoate Bryant Ranch Prepack 2022-03-21
70518-2769-00 30 CAPSULE in 1 BLISTER PACK (70518-2769-0) Hydroxyzine Pamoate REMEDYREPACK INC. 2020-06-08
76420-0920-01 100 CAPSULE in 1 BOTTLE (76420-920-01) Hydroxyzine Pamoate Asclemed USA, Inc. 2025-02-18
76420-0920-05 500 CAPSULE in 1 BOTTLE (76420-920-05) Hydroxyzine Pamoate Asclemed USA, Inc. 2025-02-18
76420-0920-30 30 CAPSULE in 1 BOTTLE (76420-920-30) Hydroxyzine Pamoate Asclemed USA, Inc. 2025-02-18
76420-0920-60 60 CAPSULE in 1 BOTTLE (76420-920-60) Hydroxyzine Pamoate Asclemed USA, Inc. 2025-02-18
76420-0920-90 90 CAPSULE in 1 BOTTLE (76420-920-90) Hydroxyzine Pamoate Asclemed USA, Inc. 2025-02-18
76420-0921-01 100 CAPSULE in 1 BOTTLE (76420-921-01) Hydroxyzine Pamoate Asclemed USA, Inc. 2025-02-18
76420-0921-05 500 CAPSULE in 1 BOTTLE (76420-921-05) Hydroxyzine Pamoate Asclemed USA, Inc. 2025-02-18
76420-0921-30 30 CAPSULE in 1 BOTTLE (76420-921-30) Hydroxyzine Pamoate Asclemed USA, Inc. 2025-02-18
76420-0921-60 60 CAPSULE in 1 BOTTLE (76420-921-60) Hydroxyzine Pamoate Asclemed USA, Inc. 2025-02-18
76420-0921-90 90 CAPSULE in 1 BOTTLE (76420-921-90) Hydroxyzine Pamoate Asclemed USA, Inc. 2025-02-18
76420-0922-01 100 CAPSULE in 1 BOTTLE (76420-922-01) Hydroxyzine Pamoate Asclemed USA, Inc. 2025-02-18
76420-0922-30 30 CAPSULE in 1 BOTTLE (76420-922-30) Hydroxyzine Pamoate Asclemed USA, Inc. 2025-02-18
76420-0922-60 60 CAPSULE in 1 BOTTLE (76420-922-60) Hydroxyzine Pamoate Asclemed USA, Inc. 2025-02-18
76420-0922-90 90 CAPSULE in 1 BOTTLE (76420-922-90) Hydroxyzine Pamoate Asclemed USA, Inc. 2025-02-18
Observed labelers: Asclemed USA, Inc. (14) · Teva Pharmaceuticals USA, Inc. (5) · Bryant Ranch Prepack (1) · REMEDYREPACK INC. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.